Image

A Novel Accessible and Widespread Healthcare Service Model Based on Technology Innovation for Objective (Early) Diagnosis and Therapeutic Monitoring of Parkinson's Disease Promoting Continuity of Care

A Novel Accessible and Widespread Healthcare Service Model Based on Technology Innovation for Objective (Early) Diagnosis and Therapeutic Monitoring of Parkinson's Disease Promoting Continuity of Care

Recruiting
50-80 years
All
Phase N/A

Powered by AI

Overview

The present study aims to use the SensMode System - a system composed of wearable devices for upper and lower limb movement analysis and electronic device for data acquisition and processing - on healthy subjects, subjects with idiopathic hyposmia, patients with Parkinson's disease, and subjects with de-novo drug-naïve extrapyramidal syndrome. The purpose is to identify normative data of objective motor measures obtained with such a system, as well as to increase knowledge about the potential contribution such a solution can make to the preclinical diagnosis of Parkinson's disease and the management of patients with this disease.

Eligibility

Inclusion Criteria:

  1. Healthy subjects - Inclusion Criteria:
    • Adult subjects, both sexes, aged 50-80 years old
    • MMSE score >= 24 absence of olfactory deficit detected on IOIT olfactory test (22). Age class 50-59 years: normal with score <=5; age class 60-69 years: normal with score <=6; age class > 70 years: normal with score <=7
    • absence of neurological diseases
    • absence of functional deficit in the sphere of locomotion as a result of traumatic injury or from other cause to the upper and/or lower limbs and/or pelvis and/or spine
    • expression of informed consent to participate in the study
  2. Subjects with Parkinson's disease -- Inclusion criteria:
    • adult subjects, both sexes, 50-80 years of age
    • MMSE score >= 24
    • subjects with Parkinson's disease in the absence of motor fluctuations and dyskinesias, or subjects with Parkinson's disease with mild motor fluctuations throughout the day, but to be examined in the ON phase and in the absence of dyskinesias
    • Hoehn and Yahr stage 1, 2, 3
    • absence of functional deficit in the sphere of locomotion as a result of traumatic injury or from other cause to the upper and/or lower limbs and/or pelvis and/or spine
    • expression of informed consent to participate in the study

Exclusion Criteria:

  1. Healthy subjects - Exclusion criteria:
    • denial of informed consent to participate in the study
    • Presence of olfactory deficit detected on IOIT olfactory test. Age class 50-59 years: hyposmia with score >=6; age class 60-69 years: hyposmia with score >=7; age class > 70 years: hyposmia with score >=8
    • body weight greater than 120 kg
    • insufficient degree of cooperation
    • malignant neoplasm in progress or with negative follow-up of less than 6 years
    • structured joint stiffness in the upper and/or lower extremities preventing proper execution of movements
    • paresis and/or plegia of upper and/or lower limb muscle groups from both peripheral and central nerve injury
    • mono/multi/poly sensory and/or motor neuropathy
    • chronic inflammatory diseases with joint involvement of the upper and/or lower limbs
    • vertiginous syndromes in the acute phase
    • neurodegenerative diseases
    • fever
    • venous thrombosis
    • cardiovascular disorders or other acute or chronic conditions capable of affecting the proper performance of motor exercises
    • spinal or joint pain of various etiologies that may affect the performance of motor exercises
    • positive history of recurrent acute cervico-brachialgia and/or lumbosciatica
  2. Subjects with Parkinson's disease - Exclusion criteria:
    • Denial of informed consent to participate in the study
    • Hoenn and Yahr stage 4, 5
    • Patient who needs to use an aid (cane or walker) while walking or cannot walk unless aided by a person
    • body weight greater than 120 kg
    • insufficient degree of cooperation
    • malignant neoplasm in place or with negative follow-up of less than 6 years
    • structured joint stiffness in the upper and/or lower extremities that prevents proper execution of movements
    • paresis and/or plegia of upper and/or lower limb muscle groups from both peripheral and central nerve injury mono/multi/poly sensory and/or motor neuropathy
    • chronic inflammatory diseases with joint involvement of the upper and/or lower limbs
    • vertiginous syndromes in the acute phase
    • neurodegenerative diseases, excluding Parkinson's disease
    • fever
    • venous thrombosis
    • cardiovascular disorders or other acute or chronic conditions capable of affecting the proper performance of motor exercises
    • spinal or joint pain of various etiologies that may affect the performance of motor exercises
    • positive history of recurrent acute cervico-brachialgia and/or low back pain

Study details
    Parkinson Disease
    Healthy Adult

NCT06907589

Scuola Superiore di Studi Universitari e di Perfezionamento Sant'Anna

15 October 2025

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.